Legal

DJS Law Group says Regeneron faces class action over Fianlimab-Libtayo trial claims

Atlas Watchline · August 21, 2026

Key facts

What happened

DJS Law Group is reminding investors about a class action lawsuit against Regeneron Pharmaceuticals, Inc

Key facts

Why it matters

Regeneron Pharmaceuticals, Inc. is identified as a public company with ticker NASDAQ: REGN

Key facts

The details

The alleged legal violations referenced are Sections 10(b) and 20(a) of the Securities Exchange Act of…

Atlas Watchline

Read the full report

DJS Law Group says investors can contact the firm about a class action against Regeneron Pharmaceuticals…

Read on Atlas Watchline

Read on Atlas Watchline